At a glance
ClinicalIndex Comparison RecordN/ACompleted· 191 enrolled
Drug / intervention
Cytosponge™ Cell Collection Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment of a Minimally Invasive Esophageal Cytology Collection System in Patients With Barrett's Esophagus or GERD Symptoms
In Brief
A clinical study evaluating Cytosponge™ Cell Collection Device for Barrett's Esophagus and GERD. Completed, enrolled 191 participants across 5 sites.
Detailed Summary
This study will assess the Minimally Invasive Esophageal Cytology Collection System in Patients with Barrett's Esophagus or GERD Symptoms.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBarrett's Esophagus, GERD
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 2015
Enrollment StartAug 2015
Primary CompletionApr 2018
Study CompletionJun 2018
TodayJul 2026
First PostedMar 23, 2015
Enrollment StartAug 1, 2015
Primary CompletionApr 24, 2018
Study CompletionJun 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 11.3 years ago
Interventions
Cytosponge™ Cell Collection Devicedevice
Cytosponge™ Cell Collection Device is indicated for use in the collection and retrieval of surface cells in the esophagus.